Astroglial activation: Current concepts and future directions
Alzheimer's & Dementia · 2024-04 · 20 (4) · 3034-3053
DOI: 10.1002/alz.13678 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 02.02.2024. Verfasst von Paul Edison. Beteiligte Einrichtung: Division of Neurology, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Alzheimer Disease. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Astrocytes are abundantly and ubiquitously expressed cell types with diverse functions throughout the central nervous system. Astrocytes show remarkable plasticity and exhibit morphological, molecular, and functional remodeling in response to injury, disease, or infection of the central nervous system, as evident in neurodegenerative diseases. Astroglial mediated inflammation plays a prominent role in the pathogenesis of neurodegenerative diseases. This review focus on the role of astrocytes as essential players in neuroinflammation and discuss their morphological and functional heterogeneity in the normal central nervous system and explore the spatial and temporal variations in astroglial phenotypes observed under different disease conditions. This review discusses the intimate relationship of astrocytes to pathological hallmarks of neurodegenerative diseases. Finally, this review considers the putative therapeutic strategies that can be deployed to modulate the astroglial functions in neurodegenerative diseases. Highlights Astroglia mediated neuroinflammation plays a key role in the pathogenesis of neurodegenerative diseases. Activated astrocytes exhibit diverse phenotypes in a region‐specific manner in brain and interact with β‐amyloid, tau, and α‐synuclein species as well as with microglia and neuronal circuits. Activated astrocytes are likely to influence the trajectory of disease progression of neurodegenerative diseases, as determined by the stage of disease, individual susceptibility, and state of astroglial priming. Modulation of astroglial activation may be a therapeutic strategy at various stages in the trajectory of neurodegenerative diseases to modify the disease course.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK.
- Division of Psychological medicine and clinical neurosciences, School of Medicine, Cardiff University, Wales, UK.
ORCID-Profile: Paul Edison
Zitieren
APA
Edison, P. (2024). Astroglial activation: Current concepts and future directions. Alzheimer's & Dementia, 20(4), 3034-3053. https://doi.org/10.1002/alz.13678
Vancouver
Edison P. Astroglial activation: Current concepts and future directions. Alzheimer's & Dementia. 2024;20(4):3034-3053. doi:10.1002/alz.13678
BibTeX
@article{Edison2024,
author = {Edison, Paul},
title = {Astroglial activation: Current concepts and future directions},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {4},
pages = {3034--3053},
doi = {10.1002/alz.13678}
}
EUVIMED